Evidence map›Paper›PMID 22639229›Full record

ArticleJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2012

Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice.

Tyrell J Simkins, Kelly L Janis, Alison K McClure, Bahareh Behrouz, Samuel S Pappas, Andreas Lehner, Norbert E Kaminski, John L Goudreau, Keith J Lookingland, Barbara L F Kaplan

Abstract readComparative Study
In one paragraph

Article in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tyrell J SimkinsNeuroscience Program, Michigan State University, East Lansing, MI 48824, USA. simkinst@msu.edu
Kelly L Janis
Alison K McClure
Bahareh Behrouz
Samuel S Pappas
Andreas Lehner
Norbert E Kaminski
John L Goudreau
Keith J Lookingland
Barbara L F Kaplan
Michigan State University · US

Funding

THC impairment of CD4/CD8 T cell-mediated host resistance to HIV and influenzaR01DA007908 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI KAMINSKI, NORBERT E · 1992 to 2013
$3.0M
NIDA NIH HHS R01 DA007908
6 · The paper itself

Abstract

Motor dysfunctions of Parkinson Disease (PD) are due to the progressive loss of midbrain nigrostriatal dopamine (NSDA) neurons. Evidence suggests a role for cannabinoid receptors in the neurodegeneration of these neurons following neurotoxicant-induced injury. This work evaluates NSDA neurons in CB1/CB2 knockout (KO) mice and tests the hypothesis that CB1/CB2 KO mice are more susceptible to neurotoxicant exposure. NSDA neuronal indices were assessed using unbiased stereological cell counting, high pressure liquid chromatography coupled with electrochemical detection or mass spectrometry, and Western blot. Results reveal that CB1 and CB2 cannabinoid receptor signaling is not necessary for the maintenance of a normally functioning NSDA neuronal system. Mice lacking CB1 and CB2 receptors were found to be equally susceptible to the neurotoxicant 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). These studies support the use of CB1/CB2 KO mice for investigating the cannabinoid receptor-mediated regulation of the NSDA neuronal system in models of PD.

Indexed as

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAnimalsCorpus StriatumDopamine D2 Receptor AntagonistsDopaminergic NeuronsMaleMiceMice, Inbred C57BLMice, KnockoutMPTP PoisoningReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Receptors, Dopamine D2Substantia Nigra1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDopamine D2 Receptor AntagonistsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Receptors, Dopamine D2

Identifiers

PMID22639229
PMCPMC3479639
OpenAlexW2117811796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.